The expert panel describes outstanding clinical research needs in DLBCL and what research underway they find exciting. Expert clinicians describe which factors they consider when selecting between these two interventions for DLBCL management. An expert panel discusses utilizing molecular strategies to determine treatment decisions for DLBCL. In this DLBCL roundtable, experts share which novel agents or combinations they are most interested in. Ruemu Birhiray, MD, leads an expert roundtable on the current treatment pathway in DLBCL. The expert panel assesses the current and expected utility for clinicians of MRD in DLBCL management decisions.